Strange: Bullish IGMS Analysts Actually See -27.09% Downside
February 24, 2020 at 09:03 AM EST
Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with IGM Biosciences Inc (IGMS). The average 12-month price target for IGMS — averaging the work of 4 analysts — reveals an average price target of $44.25/share..